In the eleventh episode of BYOB: The Healthcare Podcast, the group welcome Erin Sietstra who is the Head of Investments at Hopelab. Hopelab describes themselves as a team of behavioral scientists, designers, impact investors, and digital tech experts who strive to combine the inspiration of hope with the rigors of science Erin shares her journey as a strategy consultant to leading investments for an organization that leads in the behavior change technology space. Join the conversation with the crew as they learn about impact investing from Erin and be sure to follow her on Twitter @erinsietstra!
ERIN SIETSTRA – HOPELAB
Erin leads Hopelab Ventures, where she is responsible for Hopelab’s impact investments in companies that aim to improve the health and well-being of teens and young adults. She sources, executes, and manages investments, positioning Hopelab as both a financial and a strategic partner to entrepreneurs, thought leaders, and innovators. Prior to Hopelab, she led Transactions and Business Analytics at Johnson & Johnson Innovation, and she began her career as a strategy consultant at Leerink Partners, a healthcare-focused boutique. Erin holds an MBA with a Certificate in Public Management & Social Innovation from Stanford and a BA in Biology from Harvard.
Hopelab focuses specifically on mental health and well-being outcomes for the BIPOC and LGBTQ+ young community. Through Hopelab’s investment initiative—Hopelab Ventures, invests and partners with entrepreneurs, thought leaders, and innovators who share the commitment that Hopelab Ventures is looking to execute.
The crew asked Erin the following questions:
- Can you speak to the great work that Hopelab does and who they are?
- As the Head of Investments at Hopelab, what does your work entail?
- How did you carve a path to be at Hopelab today?
- Your background has been in myriad of avenues in healthcare, can you talk to us about what led to your decisions to follow the opportunities and organizations you have worked at?
- A focus on health equity seems to be a trend in your career, can you talk more about what that means to you?
In Episode 11, Talking with Nakin covers the deal that was announced in December between the EHR giant, Cerner and the multinational computer software conglomerate, Oracle. The deal was announced as an all-cash tender offer for $95.00 per share, or approximately $28.3 billion in equity value. “Working together, Cerner and Oracle have the capacity to transform healthcare delivery by providing medical professionals with better information—enabling them to make better treatment decisions resulting in better patient outcomes,” said Larry Ellison, Chairman and Chief Technology Officer, Oracle. Joe and Freddy answer questions from Nakin on how the continued investment from large technology giants like Oracle will have across healthcare. Join us with your favorite drink for Episode 11!
